Navigation Links
Edwards Lifesciences' Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
Date:4/3/2008

IRVINE, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a global leader in products and technologies to treat advanced cardiovascular disease, today announced that its chairman and chief executive officer, Michael A. Mussallem, has adopted a pre-arranged stock trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. The plan replaces a similar plan that expired last month.

The new plan will provide a vehicle for Mussallem to exercise Edwards stock options due to expire in 2010. Rule 10b5-1 stock trading plans allow corporate executives to adopt written, pre-arranged stock trading plans to buy or sell a specified number of shares of company stock. Such plans may minimize any market effect of stock sales or purchases by spreading them out over an extended period of time. The new plan provides for the exercise and sale of up to 14,000 shares per month.

Mussallem presently is in full compliance with the company's stock ownership guidelines for its executive officers and intends to remain in compliance throughout this stock trading plan. Under these guidelines, Mussallem is required to own shares of company stock with an aggregate market value equal to six times his base salary. Transactions under this plan will be disclosed publicly through Form 144 and Form 4 filings with the U.S. Securities and Exchange Commission (SEC). The Form 4 filings will also be posted on Edwards' investor relations web site at http://www.edwards.com/InvestorRelations.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
2. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
3. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
4. Edwards Lifesciences Reports Strong Fourth Quarter Sales
5. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
6. Edwards Lifesciences to Present at the Southern California Investor Conference
7. Edwards Lifesciences Announces Schedule of Activities at TCT 2007
8. Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007
9. Elizabeth Edwards to Join SEIU Activists at Conference
10. Exciting New Plan from John Edwards on AIDS; Plan is Bold and Achievable, say New Hampshire Activists
11. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Fujifilm Sees Significant Growth of Managed Services Business 2Health News:Fujifilm Sees Significant Growth of Managed Services Business 3Health News:ProStor InfiniVault-DICOM Storage System Debuts in Rorke Data Booth at RSNA 2Health News:ProStor InfiniVault-DICOM Storage System Debuts in Rorke Data Booth at RSNA 3Health News:TEAC Forms Strategic Alliance With SST Group, Inc. to Distribute Its Next Generation Medical Disc Publishing Systems Into Medical Market 2Health News:TEAC Forms Strategic Alliance With SST Group, Inc. to Distribute Its Next Generation Medical Disc Publishing Systems Into Medical Market 3Health News:TEAC Forms Strategic Alliance With SST Group, Inc. to Distribute Its Next Generation Medical Disc Publishing Systems Into Medical Market 4Health News:New statistical model could help reduce breast-lesion biopsies 2Health News:Fujifilm Acquires Information Systems Vendor Empiric 2Health News:Fujifilm Acquires Information Systems Vendor Empiric 3Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 2Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 3Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 4Health News:Siemens Focuses on Role-Based, Context-Sensitive and Knowledge-Driven Solutions 5
Breaking Medicine Technology:Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 1Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 2Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 3Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 1Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 2Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 3